Consistent with our in vitro results in uveal melanoma with reduced ADA expression, treatment with 20 mg/kg body weight (b.w.)of cordycepin significantly suppressed the tumor growth in 92.1 uveal melanoma xenografts with low ADA protein (Figure 1H–J). The gene discussed is ADA; the disease is neoplasm.